Abcellera Biologics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $8,955 | $17,084 | $4,235 | $5,050 |
Gross Profit | 8,955 | 10,025 | 4,235 | 5,050 |
EBITDA | -40,224 | -38,833 | -51,902 | -55,311 |
EBIT | -45,470 | -45,893 | -58,507 | -69,211 |
Net Income | -57,119 | -34,727 | -45,621 | -34,210 |
Net Change In Cash | 8,955 | 17,084 | 4,235 | 5,050 |
Free Cash Flow | -61,522 | -45,769 | -22,190 | -23,630 |
Cash | 108,159 | 92,437 | 159,266 | 156,325 |
Basic Shares | 298,875 | 298,508 | 297,692 | 294,589 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $28,833 | $38,025 | $485,424 | $11,611 |
Gross Profit | 28,833 | 38,025 | 418,988 | 11,611 |
EBITDA | -204,148 | -192,158 | 260,167 | -154 |
EBIT | -301,146 | -223,052 | 227,065 | -2,001 |
Net Income | -162,857 | -146,398 | 158,519 | -2,210 |
Net Change In Cash | 28,833 | 38,025 | 485,424 | 11,611 |
Cost of Revenue | -76,893 | -91,549 | ||
Free Cash Flow | -186,952 | -121,384 | 204,700 | 186,132 |
Cash | 156,325 | 133,320 | 386,535 | 476,142 |
Basic Shares | 294,327 | 289,166 | 314,827 | 318,294 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.19 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.12 |
